Galmed Pharmaceuticals (GLMD) Stock Chart & Stock Price History $1.57 0.00 (0.00%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$1.59 +0.02 (+1.53%) As of 10/3/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Galmed Pharmaceuticals Stock Price Performance The Galmed Pharmaceuticals (GLMD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 62.62%, with a year-to-date return of -50.78%. In the past month, the stock has increased 22.66%, reflecting recent market activity. As of the latest close, Galmed Pharmaceuticals traded at $1.57 with a market cap of $2.59 million and volume of 64,150 shares. Five years ago, the stock traded at a split-adjusted price of $649.80, representing a 99.76% decrease over that period. At the time, it had a market cap of $76.22 million and a volume of 169 shares. Receive GLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+12.95%1 Month Performance+22.66%3 Month Performance-13.02%Year-To-Date Performance-50.78%1 Year Performance-62.62%5 Year Performance-99.76% GLMD Stock Chart for Saturday, October, 4, 2025 GLMD Chart by TradingView Galmed Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025$1.57$1.57$1.63$1.5464,150 shs$2.59 million10/02/2025$1.55$1.57+1.29%$1.61$1.5037,833 shs$2.59 million10/01/2025$1.38$1.55+12.32%$1.55$1.39162,583 shs$2.56 million09/30/2025$1.39$1.38-0.72%$1.45$1.3741,574 shs$2.28 million09/29/2025$1.40$1.39-0.71%$1.42$1.3641,116 shs$2.29 million09/26/2025$1.38$1.40+1.45%$1.42$1.3539,797 shs$2.31 million09/25/2025$1.44$1.38-4.17%$1.46$1.3660,023 shs$2.28 million09/24/2025$1.47$1.44-2.04%$1.47$1.4430,868 shs$2.38 million09/23/2025$1.47$1.47$1.53$1.4544,208 shs$2.43 million09/22/2025$1.46$1.47+0.68%$1.50$1.4460,434 shs$2.43 million Get the Latest News and Ratings for GLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025$1.51$1.46-3.31%$1.52$1.4571,359 shs$2.41 million09/18/2025$1.49$1.51+1.68%$1.55$1.4595,888 shs$2.46 million09/17/2025$1.48$1.49+0.34%$1.55$1.4764,278 shs$2.45 million09/16/2025$1.46$1.48+1.37%$1.52$1.4268,325 shs$2.44 million09/15/2025$1.51$1.46-3.31%$1.56$1.4579,914 shs$2.42 million09/12/2025$1.55$1.51-2.58%$1.60$1.5057,814 shs$2.50 million09/11/2025$1.41$1.55+9.93%$1.55$1.41127,159 shs$2.56 million09/10/2025$1.46$1.41-3.09%$1.50$1.40182,825 shs$2.33 million09/09/2025$1.37$1.46+6.21%$1.47$1.34203,708 shs$2.41 million09/08/2025$1.36$1.37+0.73%$1.40$1.34101,426 shs$2.26 million09/05/2025$1.28$1.36+6.25%$1.38$1.2662,059 shs$2.24 million09/04/2025$1.29$1.28-0.78%$1.31$1.2537,202 shs$2.11 million09/03/2025$1.27$1.29+1.57%$1.31$1.24126,482 shs$2.13 million Related Companies DWTX Stock Chart ADXN Stock Chart APM Stock Chart BFRI Stock Chart HCWB Stock Chart INAB Stock Chart CELZ Stock Chart AEON Stock Chart PBM Stock Chart KPRX Stock Chart Receive GLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLMD) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredLost Decade warning – do this nowWith the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
